Mar 10, 2020 · Progenics Pharmaceuticals (PGNX) stock traded 872309 shares in most recent trading session as compared to an average volume of 910.10K shares. It shows that the shares were traded in the recent trading session and traders shown interest in PGNX stock. Shares of the Progenics Pharmaceuticals (PGNX) lost -11.48% to trade at $4.01 on Monday trading session.

21 Jan 2020 The Board of Directors of Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), under which Lantheus would acquire Progenics in an all-stock transaction. and 1404); and imaging analysis technology (aBSI and PSMA AI). 9 Aug 2018 Crowdsourced stock and analyst ratings and analysis for Progenics Pharmaceuticals Inc. ($PGNX) from the leading crowdsourced stock rating  20 Jul 2016 PGNX Technical Analysis. Progenics Pharmaceuticals. PGNX opened trading yesterday at $5.51 which was up from the previous days trading of  13 Mar 2020 A look at its technical shows that PGNX's 50-day SMA is 4.67 while its 200-day SMA stands at 4.96. The stock has a high of $6.37 for the year  Progenics Pharmaceuticals, Inc. (PGNX) Stock Analysis ... Get breaking news and analysis on Progenics Pharmaceuticals, Inc. (PGNX) stock, price quote and chart, trading and investing tools. PGNX Stock Price | Progenics Pharmaceuticals Inc. Stock ...

3 Wall Street analysts have issued 1-year target prices for Progenics Pharmaceuticals' shares. Their forecasts range from $10.00 to $14.00. On average, they 

13 Mar 2020 A look at its technical shows that PGNX's 50-day SMA is 4.67 while its 200-day SMA stands at 4.96. The stock has a high of $6.37 for the year  Progenics Pharmaceuticals, Inc. (PGNX) Stock Analysis ... Get breaking news and analysis on Progenics Pharmaceuticals, Inc. (PGNX) stock, price quote and chart, trading and investing tools. PGNX Stock Price | Progenics Pharmaceuticals Inc. Stock ...

Learn about PGNX with our data and independent analysis including price, star rating, valuation, dividends, and Stocks by Morningstar Classification 

Mar 10, 2020 · Progenics Pharmaceuticals (PGNX) stock traded 872309 shares in most recent trading session as compared to an average volume of 910.10K shares. It shows that the shares were traded in the recent trading session and traders shown interest in PGNX stock. Shares of the Progenics Pharmaceuticals (PGNX) lost -11.48% to trade at $4.01 on Monday trading session. PGNX - Progenics Pharmaceuticals Stock Price - Barchart.com

PGNX Stock Analysis Overview . What this means: Progenics Pharmaceuticals (PGNX) gets an Overall Rank of 70, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing. Progenics Pharmaceuticals Inc. (PGNX) Analyst Ratings ...

PGNX:NASDAQ GS Stock Quote - Progenics Pharmaceuticals Inc ...

13 Mar 2020 A look at its technical shows that PGNX's 50-day SMA is 4.67 while its 200-day SMA stands at 4.96. The stock has a high of $6.37 for the year  Progenics Pharmaceuticals, Inc. (PGNX) Stock Analysis ... Get breaking news and analysis on Progenics Pharmaceuticals, Inc. (PGNX) stock, price quote and chart, trading and investing tools. PGNX Stock Price | Progenics Pharmaceuticals Inc. Stock ... PGNX | Complete Progenics Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Progenics Pharmaceuticals Inc. (PGNX) Stock Price, Quote ...

Progenics Pharmaceuticals Inc (PGNX) Stock Analysis ... Mar 18, 2020 · Find out if PGNX is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on PGNX. PGNX | Progenics Pharmaceuticals Inc. Stock Price & News - WSJ View the latest Progenics Pharmaceuticals Inc. (PGNX) stock price, news, historical charts, analyst ratings and financial information from WSJ. PGNX - Research and Analysis for PROGENICS …